Scarica l'app Stockscreener
5.13
1.72%
-0.09
Precedente Chiudi:
$5.22
Aprire:
$5.03
Volume 24 ore:
276.40K
Relative Volume:
0.37
Capitalizzazione di mercato:
$281.89M
Reddito:
$124.00K
Utile/perdita netta:
$-49.99M
Rapporto P/E:
-3.0355
EPS:
-1.69
Flusso di cassa netto:
$-31.03M
1 W Prestazione:
-8.39%
1M Prestazione:
-7.73%
6M Prestazione:
-2.84%
1 anno Prestazione:
-1.16%
Intervallo 1D:
$5.03
$5.27
Intervallo di 1 settimana:
$5.03
$5.80
Portata 52W:
$3.785
$14.60
Candel Therapeutics Inc Stock (CADL) Company Profile
Nome
Candel Therapeutics Inc
Settore
Industria
Telefono
617-916-5445
Indirizzo
117 KENDRICK STREET, NEEDHAM
Confronta CADL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CADL
Candel Therapeutics Inc
|
5.135 | 286.55M | 124.00K | -49.99M | -31.03M | -1.69 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.59 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
632.18 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
426.06 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
841.34 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.51 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Candel Therapeutics Inc Stock (CADL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-28 | Iniziato | Stephens | Overweight |
| 2025-09-03 | Downgrade | BofA Securities | Buy → Neutral |
| 2025-06-30 | Ripresa | H.C. Wainwright | Buy |
| 2025-02-20 | Iniziato | Citigroup | Buy |
| 2025-02-19 | Iniziato | Canaccord Genuity | Buy |
| 2025-02-07 | Iniziato | BofA Securities | Buy |
| 2022-12-02 | Iniziato | H.C. Wainwright | Buy |
| 2021-11-19 | Iniziato | BMO Capital Markets | Outperform |
| 2021-08-23 | Iniziato | Credit Suisse | Outperform |
| 2021-08-23 | Iniziato | Jefferies | Buy |
| 2021-08-23 | Iniziato | UBS | Buy |
Mostra tutto
Candel Therapeutics Inc Borsa (CADL) Ultime notizie
Candel Therapeutics to present phase 3 prostate cancer trial data at SITC - Investing.com
Candel Therapeutics to highlight immunotherapy advances at SITC 2025 - Proactive financial news
Candel Therapeutics Presents Innovative Immunotherapy Data at SITC 2025 Annual Meeting - Quiver Quantitative
Candel Therapeutics Showcases Immunotherapy Leadership at SITC 2025, Demonstrating Integration of Clinical Innovation, Multi-Omics, and Artificial Intelligence to Advance Next-Generation Immunotherapies in Solid Tumors - GlobeNewswire Inc.
Can Candel Therapeutics Inc. stock weather global recessionWeekly Profit Analysis & Technical Pattern Recognition Alerts - newser.com
How Candel Therapeutics Inc. stock performs in stagflationQuarterly Portfolio Report & Expert Approved Momentum Ideas - newser.com
Candel Therapeutics to present at Jefferies Global Healthcare Conference - Proactive financial news
Can volume confirm reversal in Candel Therapeutics Inc.CEO Change & Daily Entry Point Alerts - newser.com
What the charts say about Candel Therapeutics Inc. todayTrade Signal Summary & Capital Efficient Trading Techniques - newser.com
Will Candel Therapeutics Inc. stock reach all time highs in 20252025 Biggest Moves & AI Powered Market Entry Strategies - newser.com
Candel Therapeutics to Present at Jefferies Global Healthcare Conference in London - The Manila Times
Candel Therapeutics, Inc. CEO Paul Peter Tak to Present at Jefferies Global Healthcare Conference 2025 - Quiver Quantitative
Will Candel Therapeutics Inc. see short term momentumJuly 2025 Volume & Capital Efficient Trading Techniques - newser.com
What technical models suggest about Candel Therapeutics Inc.’s comebackTrade Entry Report & Expert Curated Trade Setup Alerts - newser.com
Is Candel Therapeutics Inc. building a consolidation baseJuly 2025 Market Mood & Weekly Momentum Picks - newser.com
How geopolitical tensions affect Candel Therapeutics Inc. stock2025 Biggest Moves & Free High Accuracy Swing Entry Alerts - newser.com
How Candel Therapeutics Inc. stock compares to growth peersJuly 2025 Drop Watch & Expert Curated Trade Setup Alerts - newser.com
Intraday pattern recognizer results for Candel Therapeutics Inc.2025 Risk Factors & Daily Chart Pattern Signals - newser.com
What’s next for Candel Therapeutics Inc. stock priceOil Prices & Detailed Earnings Play Strategies - newser.com
Can Candel Therapeutics Inc. stock sustain revenue growth2025 Top Decliners & Step-by-Step Swing Trade Plans - newser.com
Why analysts upgrade Candel Therapeutics Inc. stockJuly 2025 Recap & Accurate Buy Signal Notifications - newser.com
Will Candel Therapeutics Inc. stock outperform international peersMarket Movement Recap & Free Technical Pattern Based Buy Signals - newser.com
Will Candel Therapeutics Inc. stock benefit from automationLong Setup & Real-Time Stock Entry Alerts - newser.com
Candel Therapeutics Inc Azioni (CADL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.46%
0.67%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):